We summarize the clinical experience and evidence for conversion therapy in patients with ‘potentially resectable’ HCC from four perspectives: 1) defining the target population for conversion therapy, ...

In Q4 2024, the average Conversion Rate was 4.8% (averaging across all countries, platforms, and industries) according to our research. This overall average benchmark is limited in its usefulness. To ...